Cite Filings / KYMR / 0001628280-26-026598
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Kymera Therapeutics, Inc. · Filed 2026-04-22 · Acc 0001628280-26-026598

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-04-24 4 Director sold 6,000 shares at an average $89.96 ($539,772)
  • 2026-04-24 4 Chief Operating Officer sold 300 shares at $90.00 ($27,000)
  • 2026-04-22 144 Sale of Securities
  • 2026-04-22 144 Sale of Securities
  • 2026-04-22 144 Sale of Securities
  • 2026-04-16 4 Director sold 9,494 shares at an average $90.01 ($854,539)
  • 2026-04-15 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…